Healthcare -
Biotechnology - NASDAQ - US
$ 46.98
1.8 %
$ 3.62 B
Market Cap
-7.91
P/E
PTCT - SHORT-TERM DEBT
Short-term Debt PTCT - PTC Therapeutics, Inc.
210 M
LAST VALUE
11.20%
2 YEAR CAGR
78.31%
5 YEAR CAGR
131.00%
10 YEAR CAGR